Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study by Zili Hu, Zili Hu, Zili Hu, Zhoutian Yang, Zhoutian Yang, Zhoutian Yang, Zibo Fu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zeliang Ma, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang

Get full text

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Qianyu Wang, Li Hu, Li Hu, Li Hu, Xiaoxian Sima, Xiaoxian Sima, Xiaoxian Sima, Juncheng Wang, Juncheng Wang, Juncheng Wang, Dandan Hu, Dandan Hu, Dandan Hu, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yizhen Fu, Yizhen Fu, Yizhen Fu

Get full text

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Weijie Wu, Weijie Wu, Weijie Wu, Zhiwen Hu, Zhiwen Hu, Zhiwen Hu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zili Hu, Zili Hu, Zili Hu, Yangxun Pan, Yangxun Pan, Yangxun Pan, Juncheng Wang, Juncheng Wang, Juncheng Wang, Jinbin Chen, Jinbin Chen, Jinbin Chen, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Minshan Chen, Minshan Chen, Minshan Chen, Dandan Hu, Dandan Hu, Dandan Hu

Get full text

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation by Yaoyun Kuang, Hengxu Mao, Xiaoyun Huang, Minshan Chen, Wei Dai, Tingting Gan, Jiaqi Wang, Hui Sun, Hao Lin, Qin Liu, Xinling Yang, Ping-Yi Xu

Get full text

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment by Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen

Get full text

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment by Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen

Get full text

YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity by Haiyan Zhang, Xiaojing Luo, Wei Yang, Zhiying Wu, Zhicong Zhao, Xin Pei, Xue Zhang, Chonghao Chen, Josh Haipeng Lei, Qingxia Shi, Qi Zhao, Yanxing Chen, Wenwei Wu, Zhaolei Zeng, Huai-Qiang Ju, Miaozhen Qiu, Jun Liu, Bin Shen, Minshan Chen, Jianjun Chen, Chu-Xia Deng, Rui-Hua Xu, Jiajie Hou

Get full text

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition) by Yu Yang, Juxian Sun, Jianqiang Cai, Minshan Chen, Chaoliu Dai, Tianfu Wen, Jinglin Xia, Mingang Ying, Zhiwei Zhang, Xuewen Zhang, Chihua Fang, Feng Shen, Ping An, Qingxian Cai, Jingyu Cao, Zhen Zeng, Gang Chen, Juan Chen, Ping Chen, Yongshun Chen, Yunfeng Shan, Shuangsuo Dang, Wei-Xing Guo, Jiefeng He, Heping Hu, Bin Huang, Weidong Jia, Kexiang Jiang, Yan Jin, Yongdong Jin, Yun Jin, Gong Li, Yun Liang, Enyu Liu, Hao Liu, Wei Peng, Zhenwei Peng, Zhiyi Peng, Yeben Qian, Wanhua Ren, Jie Shi, Yusheng Song, Min Tao, Jun Tie, Xueying Wan, Bin Wang, Jin Wang, Kai Wang, Kang Wang, Xin Wang, Wenjing Wei, Fei-Xiang Wu, Bangde Xiang, Lin Xie, Jianming Xu, Mao-Lin Yan, Yufu Ye, Jinbo Yue, Xiaoxun Zhang, Yu Zhang, Aibin Zhang, Haitao Zhao, Weifeng Zhao, Xin Zheng, Hongkun Zhou, Huabang Zhou, Jun Zhou, Xinmin Zhou, Shu-Qun Cheng, Qiu Li

Get full text